Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

ABSTRACT:

Aim

To understand the proportion of uHCC (unresectable hepatocellular carcinoma) patients who achieve successful conversion resection in a high-volume setting with state of the art treatment options.

Methods

We retrospectively reviewed all HCC patients hospitalized to our center from June 1^st, 2019 to June 1^st, 2022. Conversion rate, clinicopathological features, response to systemic and/or loco-regional therapy and surgical outcomes were analyzed.

Results

A total of 1,904 HCC patients were identified, with 1672 patients receiving anti-HCC treatment. 328 patients were considered up-front resectable. Of the remaining 1344 uHCC patients, 311 received loco-regional treatment, 224 received systemic treatment, and the remainder (809) received combinat

SUBMITTER: Zhang B 

PROVIDER: S-EPMC10199571 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature